KR20010084165A - 녹차카테킨(gtc)을 유효성분으로 하는 dna 산화적손상 억제제 - Google Patents
녹차카테킨(gtc)을 유효성분으로 하는 dna 산화적손상 억제제 Download PDFInfo
- Publication number
- KR20010084165A KR20010084165A KR1020000008987A KR20000008987A KR20010084165A KR 20010084165 A KR20010084165 A KR 20010084165A KR 1020000008987 A KR1020000008987 A KR 1020000008987A KR 20000008987 A KR20000008987 A KR 20000008987A KR 20010084165 A KR20010084165 A KR 20010084165A
- Authority
- KR
- South Korea
- Prior art keywords
- gtc
- green tea
- oxidative damage
- dna
- egcg
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
처리농도(㎍/㎖) | 535nm에서의 흡광도(Mean ±S.D.) | 억제도(%) | 50% 억제농도(㎍/㎖) |
GTC 01050100500 | 0.361±0.0010.274±0.0040.197±0.0190.133±0.0010.075±0.051 | 33.7355.0873.0187.25 | 29.3 |
EGCG 01050100 | 0.399±0.0060.270±0.0490.223±0.0130.135±0.014 | 42.6169.1788.73 | 15.4 |
비타민 E 01050100 | 0.361±0.0010.326±0.0010.306±0.0020.234±0.007 | 20.6126.3446.40 | 234.4 |
처리농도(㎍/㎖) | 535nm에서의 흡광도(Mean ±S.D.) | 억제도(%) | 50% 소거농도(㎍/㎖) |
GTC 01050100500 | 0.307±0.0040.148±0.0060.057±0.0060.027±0.0010.035±0.005 | 52.6682.6392.7393.81 | 4.0 |
EGCG 01050100 | 0.307±0.0040.086±0.0040.019±0.0020.015±0.000 | 73.2994.4695.44 | 0.9 |
비타민 E 01050100 | 0.348±0.0170.309±0.0000.290±0.0020.211±0.004 | 25.5528.8051.29 | 185.4 |
처리농도(㎍/㎖) | Tail length(㎛), OD535nm(Mean ±S.D.) | 억제도(%) |
GTC 010100200 | 168.2±13.6141.7± 8.8138.0± 0.7118.5± 8.3 | -15.717.929.5 |
EGCG 00.454.545 | 168.2±13.6168.2±33.6170.6±28.7146.4±33.3 | -0012.9 |
비타민 E 00.434.343 | 168.2±13.6163.3±13.3139.1± 4.6109.3±24.9 | -2.917.335.0 |
처리농도(㎍/㎖) | 8-OH2'dG/1052'dG,535nm에서의 흡광도(Mean ±S.D.) | 억제도(%) |
GTC 010100200 | 68.1±19.859.6±17.560.8± 1.560.0± 1.2 | -12.410.711.0 |
EGCG 00.454.545 | 68.1±19.869.6±18.054.1± 9.963.4± 0.8 | -020.56.9 |
비타민 E 00.434.343 | 112.0±19.291.6± 8.394.5±13.193.4±27.3 | -18.215.616.6 |
Claims (7)
- 에피갈로카테킨 갈레이트(C22H18O11; 458.4)를 33 내지 89%(w/w), 에피갈로카테킨(C15H14O7; 306.3)를 8 내지 27%(w/w), 에피카테킨 갈레이트(C22H18O10; 442.5)를 3 내지 7%(w/w) 함유하는 녹차카테킨(Green tea catechins, GTC)을 유효성분으로 하고, 약제학적으로 허용되는 담체를 포함하는 DNA 산화적 손상 억제제.
- 제 1항에 있어서,정제인 것을 특징으로 하는DNA 산화적 손상 억제제.
- 제 1항에 있어서,캅셀제인 것을 특징으로 하는DNA 산화적 손상 억제제.
- 제 1항에 있어서,연질캅셀제인 것을 특징으로 하는DNA 산화적 손상 억제제.
- 제 1항에 있어서,액제인 것을 특징으로 하는DNA 산화적 손상 억제제.
- 제 1항에 있어서,연고제인 것을 특징으로 하는DNA 산화적 손상 억제제.
- 제 1항에 있어서,주사제인 것을 특징으로 하는DNA 산화적 손상 억제제.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0008987A KR100398318B1 (ko) | 2000-02-24 | 2000-02-24 | 녹차카테킨(gtc)을 유효성분으로 하는 dna 산화적손상 억제제 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2000-0008987A KR100398318B1 (ko) | 2000-02-24 | 2000-02-24 | 녹차카테킨(gtc)을 유효성분으로 하는 dna 산화적손상 억제제 |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010084165A true KR20010084165A (ko) | 2001-09-06 |
KR100398318B1 KR100398318B1 (ko) | 2003-09-19 |
Family
ID=19649506
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR10-2000-0008987A KR100398318B1 (ko) | 2000-02-24 | 2000-02-24 | 녹차카테킨(gtc)을 유효성분으로 하는 dna 산화적손상 억제제 |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100398318B1 (ko) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100497003B1 (ko) * | 2002-08-30 | 2005-06-23 | 주식회사 바이오랜드 | 안구표면 질환 치료용 양막을 보존하기 위한 양막보존액 조성물 |
KR101389211B1 (ko) * | 2011-08-30 | 2014-04-24 | 인타글리오주식회사 | 녹차 추출물, 울금 추출물, 후박추출물 및 독활 추출물의 나노캡슐을 포함하는 화장료 조성물 및 그 제조방법 |
KR101452309B1 (ko) * | 2008-10-28 | 2014-10-21 | 순천향대학교 산학협력단 | 환원수 및 홍삼추출물을 포함하는 식품 조성물 |
-
2000
- 2000-02-24 KR KR10-2000-0008987A patent/KR100398318B1/ko active IP Right Grant
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100497003B1 (ko) * | 2002-08-30 | 2005-06-23 | 주식회사 바이오랜드 | 안구표면 질환 치료용 양막을 보존하기 위한 양막보존액 조성물 |
KR101452309B1 (ko) * | 2008-10-28 | 2014-10-21 | 순천향대학교 산학협력단 | 환원수 및 홍삼추출물을 포함하는 식품 조성물 |
KR101389211B1 (ko) * | 2011-08-30 | 2014-04-24 | 인타글리오주식회사 | 녹차 추출물, 울금 추출물, 후박추출물 및 독활 추출물의 나노캡슐을 포함하는 화장료 조성물 및 그 제조방법 |
Also Published As
Publication number | Publication date |
---|---|
KR100398318B1 (ko) | 2003-09-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3264934B2 (ja) | 茶のポリフェノール画分、その使用、及びそれを含有する処方物 | |
Yang et al. | Protection from oxidative damage using Bidens pilosa extracts in normal human erythrocytes | |
KR100685083B1 (ko) | 사이클로옥시게나제-2 억제제로서 효능있는 프리-비-링구조를 갖는 플라보노이드의 선별 | |
US5648377A (en) | Formulations containing carotenoids an procarotenoids combined with polyphenols in the prevention of the damages due to an abnormal production of free radicals | |
US20030105031A1 (en) | Methods for the treatment of skin disorders | |
JP2002508752A (ja) | アルツハイマー病および他のアミロイド症のための組成物および方法 | |
EP2340027A2 (en) | Methods and compositions for the treatment of cancer | |
US6737085B2 (en) | Apocynum venetum extract for use as antidepressant | |
Akkol et al. | Isolation of active constituents from cherry laurel (Laurocerasus officinalis Roem.) leaves through bioassay-guided procedures | |
Rossi et al. | Liquid chromatography/atmospheric pressure chemical ionization ion trap mass spectrometry of bilobalide in plasma and brain of rats after oral administration of its phospholipidic complex | |
KR101957632B1 (ko) | 섬유화증 예방, 개선 또는 치료용 조성물 | |
KR20040107713A (ko) | 황금 추출물 또는 이로부터 분리한 바이칼린, 바이칼레인,우고닌 또는 5,7,2,5-테트라하이드록시-8,6-디메톡시플라본을 함유하는 노화 방지 및 억제용 약학조성물 | |
KR100398318B1 (ko) | 녹차카테킨(gtc)을 유효성분으로 하는 dna 산화적손상 억제제 | |
WO2011112002A2 (ko) | 들쭉 추출물 또는 들쭉 분획물을 유효 성분으로 함유하는 황반 변성증의 치료, 예방 또는 개선용 조성물 | |
EP2411031A2 (en) | Methods and compositions for the treatment of cancer | |
KR100514916B1 (ko) | 항산화활성을 갖는 연수 추출물 및 그로부터 분리된플라보노이드 화합물을 함유한 조성물 | |
KR102279105B1 (ko) | 대추나무 뿌리 추출물을 포함하는 신장 질환의 예방 또는 치료용 조성물 | |
KR100398317B1 (ko) | 녹차카테킨(gtc)을 유효성분으로 하는 세포보호제 | |
KR100440607B1 (ko) | 프레그난 배당체 화합물 및 이를 유효성분으로 함유하는퇴행성 뇌신경계 질환의 예방 및 치료제 | |
KR20020045417A (ko) | 녹차로부터 추출된 항암효과가 우수한 폴리페놀류 화합물 | |
KR101449379B1 (ko) | 녹차로부터 루테인의 추출 방법 | |
KR20040085981A (ko) | 이나무로부터 분리한 멜라닌 생합성 저해활성을 가지는유효활성물질 및 이를 포함하는 피부미백제 | |
KR101187195B1 (ko) | 유럽종 포도의 씨 추출물을 함유하는 위장관 궤양의 예방 또는 치료용 약학 조성물 | |
KR101028865B1 (ko) | 무로부터 설포라펜을 분리하는 방법 및 이의 용도 | |
KR20030004726A (ko) | 양강의 활성 성분의 분리방법 및 이를 주성분으로 하는노화 방지제 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120817 Year of fee payment: 10 |
|
FPAY | Annual fee payment |
Payment date: 20130829 Year of fee payment: 11 |
|
FPAY | Annual fee payment |
Payment date: 20141203 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20160616 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20170627 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20180719 Year of fee payment: 16 |
|
FPAY | Annual fee payment |
Payment date: 20190819 Year of fee payment: 17 |